Assessing the impact of the new medical reform on China's pharmaceutical supply chain: the case of essential medicines distribution in Yuping, Luochan, and Minhang regions

Sam Dzever (), Zhao Guoqin () and Tang Renwu
Additional contact information
Sam Dzever: IMT-BS - MMS - Département Management, Marketing et Stratégie - TEM - Télécom Ecole de Management - IMT - Institut Mines-Télécom [Paris] - IMT-BS - Institut Mines-Télécom Business School - IMT - Institut Mines-Télécom [Paris], LITEM - Laboratoire en Innovation, Technologies, Economie et Management (EA 7363) - UEVE - Université d'Évry-Val-d'Essonne - TEM - Télécom Ecole de Management
Zhao Guoqin: Central University of Finance and Economics [Beijing]
Tang Renwu: BNU - Beijing Normal University, Zhejiang Normal University

Post-Print from HAL

Abstract: The new round of reform in the Chinese medical system has led to optimization of the country's pharmaceutical supply chain. This, in turn, has led to unprecedented opportunities and challenges for operators and consumers alike within this market. The reform has also brought about an urgent need for rigorous scientific analysis of the impact this may have on the country's pharmaceutical supply chain, especially as it relates to the rural areas. The objective of our research is to contribute to the enhancement of knowledge in this area. Specifically, our research is concerned with an empirical investigation of the impact of new medical reform on essential medicines supply chain in three rural areas of China: Yuping, Luochuan, and Minhang regions. The following questions are central to our research: To what extent is the efficiency and effectiveness of the supply chain for these products enhanced as a result of the implementation of the new medical reform? Is the level of availability and affordability of these medicines enhanced among consumers in the rural areas as a result of the reform? What is the role of rural medical institutions, such as district hospitals and outpatient clinics, in ensuring a more efficient and adequate supply mechanism for these products in the rural areas? Has the implementation of the new reform led to a more efficient management of the relationship between the essential medicines supply chain and government rural Cooperative Medical System? Three research hypotheses have been developed as the basis for addressing these issues from an empirical perspective.

Keywords: Consumer expectations; China's new medical reform; Pharmaceutical supply chain; Availability and affordability of essential medicines; Efficiency and effectiveness of the distribution network; China (search for similar items in EconPapers)
Date: 2017
References: Add references at CitEc
Citations:

Published in The China business model : originality and limits, Chandos Publishing, Elsevier, pp.119 - 144, 2017, Elsevier Asian studies series, 978-0-08-100750-1. ⟨10.1016/B978-0-08-100750-1.00006-1⟩

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-01449493

DOI: 10.1016/B978-0-08-100750-1.00006-1

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().